Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01426919 · ClinicalTrials.gov registry record
Evaluation of Biomarkers of Traumatic Brain Injury
A clinical trial of Traumatic Brain Injury, sponsored by Banyan Biomarkers.
- Completed
- Registry status
- 2,011
- Enrollment target
- 20
- Study locations
NCT01426919: Completed study of Traumatic Brain Injury, sponsored by Banyan Biomarkers.
NCT01426919 is a study of Traumatic Brain Injury that has completed, run by Banyan Biomarkers. The registered enrollment target is 2,011 participants, above the 266-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (656% higher). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01426919, a study of Traumatic Brain Injury, has completed, sponsored by Banyan Biomarkers.
- COMPLETED
- Registry status
- 2,011 participants
- Enrollment target
- 20
- Study locations
Study Summary
The primary objective of this study is to evaluate the utility of the Banyan UCH-L1/GFAP Detection Assay as an aid in the evaluation of suspected traumatic brain injury (Glasgow Coma Scale score 9-15) in conjunction with other clinical information within 12 hours of injury to assist in determining the need for a CT scan of the head.
Conditions Studied
Interventions
- OTHER Head CT scan and blood draw within 12 hours of injury
Study Locations (20)
Virginia
- University of Virginia - Charlottesville
- Carilion New River Valley - Christiansburg
- Virginia Commonwealth University - Richmond
Other
- Charité Universitätsmedizin Berlin - Campus Benjamin Franklin - Berlin
- Charité Universitätsmedizin Berlin - Campus Virchow Klinikum - Berlin
- University of Heidelberg - Heidelberg
Florida
- University of Florida - Gainesville
- Tallahassee Neurological Clinic - Tallahassee
Michigan
- Wayne State University - Detroit Receiving Hospital - Detroit
- Wayne State University - Sinai Grace Hospital - Detroit
Texas
- University Medical Center Brackenridge - Austin
- Baylor College of Medicine/Ben Taub General Hospital - Houston
California
- University of California San Diego - San Diego
Connecticut
- Hartford Hospital - Hartford
Massachusetts
- University of Massachusetts Medical School - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,011 participants |
| Start Date | 2012-12 |
| Est. Completion | 2017-07 |
What the finished NCT01426919 record still lists
NCT01426919 is an observational study that tracks outcomes without assigning an intervention. Its 2,011 participants enrollment target places it among the larger protocols in the corpus, above the 266-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (656% higher).
The record links to 1 condition, with Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which Head CT scan and blood draw within 12 hours of injury is the first listed.
NCT01426919 names 20 study sites across 13 states, led by Virginia, Other, Florida.
Frequently Asked Questions
What is clinical trial NCT01426919 about?
NCT01426919 is a clinical study titled "Evaluation of Biomarkers of Traumatic Brain Injury". The primary objective of this study is to evaluate the utility of the Banyan UCH-L1/GFAP Detection Assay as an aid in the evaluation of suspected traumatic brain injury (Glasgow Coma Scale score 9-15) in conjunction with other clinical information within 12 hours of injury to assist in determining t...
What is the current status of trial NCT01426919?
This trial is currently completed. The enrollment target is 2,011 participants. The study started on 2012-12. Estimated completion is 2017-07.
What conditions does trial NCT01426919 study?
This clinical trial studies the following conditions: Traumatic Brain Injury.
What interventions are being tested in trial NCT01426919?
The interventions under investigation include: Head CT scan and blood draw within 12 hours of injury (OTHER).
Who is sponsoring clinical trial NCT01426919?
This trial is sponsored by Banyan Biomarkers, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01426919 being conducted?
This trial has 20 study locations across California, Connecticut, Florida, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01426919's enrollment target sits among peer trials
2,011 2nd of 171 the highest of 171 other Traumatic Brain Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
tPBM in Older Adults With Traumatic Brain Injury
RECRUITING · NA
-
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
RECRUITING · Phase 1
-
Carbon Dioxide Administration and Brain Waste Clearance
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Cortical Spreading Depolarization After Severe Traumatic Brain Injury
RECRUITING
-
A Study to Evaluate the SENSE Device's Ability to Detect TBI
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04604509 · 2,010 participants · Phase 4
Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial
- NCT04100564 · 2,009 participants · NA
LITES Task Order 0005 Prehospital Airway Control Trial (PACT)
- NCT05059444 · 2,020 participants
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia